Vote Scores
Filings read through

AstraZeneca PLC: how funds voted at the meeting of 11 Apr 2025

Ticker
AZN
Meeting
Season
year to 30 June 2025
Filers reporting
344
Ballot items
9

344 filers on Form N-PX reported votes at the AstraZeneca PLC meeting of 11 Apr 2025. The records fall into 9 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of AstraZeneca PLC has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    14 nominees. 97.2% of the reported votes are for. 81 filers withheld from or voted against at least one nominee.

    8,644 vote records from 294 filers. 0 of the 292 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 52 fund families
    • For 52
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    155 vote records from 80 filers. 4 of the 76 filers that marked the item voted against management. 4 filers gave no management mark.

    • Positions of 10 fund families
    • For 8
    • Against 1
    • Split or no vote 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    1,233 vote records from 291 filers. 0 of the 289 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 52 fund families
    • For 52
  4. Item 4: SHAREHOLDER RIGHTS AND DEFENSES: management items

    The company's items in this category are shown together, because filers word and number them differently.

    65 vote records from 24 filers. 0 of the 24 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    3,187 vote records from 295 filers. 1 of the 293 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 52 fund families
    • For 52
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    650 vote records from 244 filers. 2 of the 244 filers that marked the item voted against management.

    • Positions of 47 fund families
    • For 47
  7. Item 7: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,211 vote records from 294 filers. 1 of the 292 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 52 fund families
    • For 50
    • Against 1
    • Split or no vote 1
    • Against management 1
  8. Item 8: OTHER SOCIAL ISSUES: management items

    The company's items in this category are shown together, because filers word and number them differently.

    611 vote records from 289 filers. 2 of the 287 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 52 fund families
    • For 51
    • Against 1
    • Against management 1
  9. Item 9: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    85 vote records from 36 filers. 0 of the 34 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 7 fund families
    • For 7

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at AstraZeneca PLC, meeting of 11 Apr 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinNo reportFor
AllspringNo reportFor
American BeaconForFor
American CenturyNo reportFor
Artisan PartnersNo reportFor
BlackRock and iSharesNo reportFor
BNY MellonNo reportFor
Brighthouse FundsNo reportFor
Capital Group and American FundsNo reportFor
Charles SchwabNo reportFor
Columbia ThreadneedleNo reportFor
DimensionalNo reportFor
DWSNo reportFor
EquitableNo reportFor
Federated HermesNo reportFor
FidelityNo reportFor
First TrustForFor
Franklin TempletonNo reportFor
Goldman SachsNo reportFor
Harbor FundsForFor
Hartford FundsNo reportFor
InvescoNo reportFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonNo reportFor
John Hancock and ManulifeForFor
Lincoln FinancialNo reportFor
Lord AbbettNo reportFor
Macquarie and Delaware FundsNo reportFor
MassMutualForFor
MFSNo reportFor
Morgan Stanley, Eaton Vance and CalvertNo reportFor
NationwideNo reportFor
Natixis and Loomis SaylesAgainst, against managementFor
Neuberger BermanNo reportFor
Northern Trust and FlexSharesForFor
Nuveen and TIAANo reportFor
Pacific Life fundsNo reportFor
PGIM and PrudentialSplitFor
PIMCONo reportFor
PrincipalNo reportFor
Russell InvestmentsNo reportFor
SEINo reportFor
State Street and SPDRNo reportFor
T. Rowe PriceNo reportFor
ThriventNo reportFor
TransamericaNo reportFor
VanguardNo reportFor
Victory CapitalNo reportFor
VirtusNo reportFor
VoyaNo reportFor
WisdomTreeNo reportFor

Questions

How many filers reported votes at the AstraZeneca PLC meeting?
344 Form N-PX filers reported votes at the meeting of 11 Apr 2025. On say-on-pay, 4 of 76 filers that marked the item voted against management (5.3%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. AstraZeneca PLC reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list AstraZeneca PLC with a meeting date within three days of 11 Apr 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .